![Daniel Hunt](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Daniel Hunt
Directeur/Membre du Conseil chez Antion Biosciences SA
Postes actifs de Daniel Hunt
Sociétés | Poste | Début | Fin |
---|---|---|---|
Antion Biosciences SA
![]() Antion Biosciences SA BiotechnologyHealth Technology Antion Biosciences SA is a Swiss-based biotechnology company that develops universal cell and gene therapy products to treat diseases with significant unmet medical needs. The private company is based in Geneva, Switzerland. The company's proprietary gene silencing and co-expression gene constructs allow for a modular and tunable approach to multiplex engineering of therapeutic cells. Antion aims to develop off-the-shelf therapies with enhanced potency and improved safety to make cell and gene therapies universal and broaden access to these life-changing therapies for all patients. Antion Biosciences was founded by Michael Pepper and Roberto Speck, and the CEO is Marco Alessandrini. | Directeur/Membre du Conseil | - | - |
Historique de carrière de Daniel Hunt
Formation de Daniel Hunt
Stanford University | Undergraduate Degree |
London School of Economics & Political Science | Graduate Degree |
Statistiques
Internationale
Suisse | 2 |
Etats-Unis | 2 |
Royaume-Uni | 2 |
Opérationnelle
Director/Board Member | 1 |
Undergraduate Degree | 1 |
Graduate Degree | 1 |
Sectorielle
Consumer Services | 3 |
Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 1 |
---|---|
Antion Biosciences SA
![]() Antion Biosciences SA BiotechnologyHealth Technology Antion Biosciences SA is a Swiss-based biotechnology company that develops universal cell and gene therapy products to treat diseases with significant unmet medical needs. The private company is based in Geneva, Switzerland. The company's proprietary gene silencing and co-expression gene constructs allow for a modular and tunable approach to multiplex engineering of therapeutic cells. Antion aims to develop off-the-shelf therapies with enhanced potency and improved safety to make cell and gene therapies universal and broaden access to these life-changing therapies for all patients. Antion Biosciences was founded by Michael Pepper and Roberto Speck, and the CEO is Marco Alessandrini. | Health Technology |
- Bourse
- Insiders
- Daniel Hunt
- Expérience